Combined bone marrow-derived mesenchymal stromal cell therapy and one-way endobronchial valve placement in patients with pulmonary emphysema: A phase i clinical trial

Stem Cells Translational Medicine

Volumn 6, Issue 3, 2017, Pages 962-969

  De Oliveira, Hugo Goulart ^a,b   Cruz, Fernanda Ferreira ^c   Antunes, Mariana Alves ^c   De Macedo Neto, Amarilio Vieira ^a,b   Oliveira, Guilherme Augusto ^b   Svartman, Fabio Munhoz ^a,b   Borgonovo, Tamara ^d   Rebelatto, Carmen Lucia Kuniyoshi ^d   Weiss, Daniel J ^e   Brofman, Paulo Roberto Slud ^d   Morales, Marcelo Marcos ^c   Silva, José Roberto Lapa E ^c   Rocco, Patricia Rieken Macedo ^c  

^a HOSPITAL MOINHOS DE VENTO   (Brazil)

^b HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^c FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^d PONTIFICAL CATHOLIC UNIVERSITY OF PARANÁ   (Brazil)

^e UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

Author keywords

Chronic obstructive pulmonary disease; Endobronchial valves; Lung volume reduction; Mesenchymal stromal cells; Spirometry

Indexed keywords

C REACTIVE PROTEIN;

ADULT; AGED; ARTICLE; ASSESSMENT OF HUMANS; ASTHENIA; BONE MARROW DERIVED MESENCHYMAL STEM CELL; CELL CULTURE; CELL ISOLATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; COUGHING; DEVICE REMOVAL; DISEASE EXACERBATION; DISEASE SEVERITY; EMPYEMA; ENDOBRONCHIAL VALVE; ENDOBRONCHIAL VALVE PLACEMENT; FEMALE; FOLLOW UP; HEART ARRHYTHMIA; HEMOPTYSIS; HUMAN; HUMAN CELL; LUNG EMPHYSEMA; LUNG SURGERY; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMA CELL; PHASE 1 CLINICAL TRIAL; PNEUMOTHORAX; PROSPECTIVE STUDY; PROSTHETIC REPLACEMENT; RESPIRATORY FAILURE; RESPIRATORY THERAPEUTIC DEVICE; SINGLE BLIND PROCEDURE; THORAX RADIOGRAPHY; TREATMENT OUTCOME; CLINICAL TRIAL; CYTOLOGY; DIAGNOSTIC IMAGING; LUNG FUNCTION TEST; MESENCHYMAL STEM CELL; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PULMONARY VALVE; QUALITY OF LIFE; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; C-REACTIVE PROTEIN; FEMALE; HUMANS; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; MIDDLE AGED; PULMONARY EMPHYSEMA; PULMONARY VALVE; QUALITY OF LIFE; RESPIRATORY FUNCTION TESTS; TREATMENT OUTCOME;

EID: 85017561205     PISSN: 21576564     EISSN: 21576580     Source Type: Journal    
DOI: 10.1002/sctm.16-0315     Document Type: Article

References (30)

1. Global Strategy for the Diagnosis, Management and Prevention of COPD. Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2016. Available at http://www.goldcopd. org/. Acessed May 12, 2016.
2. Sciurba FC, Ernst A, Herth FJ et al. A randomized study of endobronchial valves for advanced emphysema. N Engl J Med 2010; 363:1233–1244.
3. Dominici M, Le Blanc K, Mueller I et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006;8:315–317.
4. Bernardo ME, Fibbe WE. Mesenchymal stromal cells: Sensors and switchers of inflammation. Cell Stem Cell 2013;13:392–402.
5. Lee JW, Fang X, Gupta N et al. Allogeneic human mesenchymal stem cells for treatment of E. coli endotoxin-induced acute lung injury in the ex vivo perfused human lung. Proc Natl Acad Sci USA 2009;106: 16357–16362.
6. Antunes MA, Abreu SC, Cruz FF et al. Effects of different mesenchymal stromal cell sources and delivery routes in experimental emphysema. Respir Res 2014;15:118.
7. Weiss DJ, Casaburi R, Flannery R et al. A placebo-controlled, randomized trial of mesenchymal stem cells in COPD. Chest 2013;143: 1590–1598.
8. Criner GJ, Cordova F, Sternberg AL et al. The National Emphysema Treatment Trial (NETT) Part II: Lessons learned about lung volume reduction surgery. Am J Respir Crit Care Med 2011;184:881–893.
9. Davey C, Zoumot Z, Jordan S et al. Bronchoscopic lung volume reduction with endobronchial valves for patients with heterogeneous emphysema and intact interlobar fissures (the BeLieVeR-HIFi trial): Study design and rationale. Thorax 2015;70:288–290.
10. de Oliveira HG, Macedo-Neto AV, John AB et al. Transbronchoscopic pulmonary emphysema treatment: 1-month to 24-month endoscopic follow-up. Chest 2006;130:190–199.
11. World Medical Association (WMA). Declaration of Helsinki: Ethical principles for medical research involving human subjects. JAMA 2013;310:2191–2194.
12. van Rikxoort EM, Goldin JG, Galperin- Aizenberg M et al. A method for the automatic quantification of the completeness of pulmonary fissures: Evaluation in a database of subjects with severe emphysema. Eur Radiol 2012;22:302–309.
13. Oliveira HG, Rambo RR, Macedo-Neto AV et al. Fissure integrity as a non-invasive method to predict volume reduction in endobronchial valve treatment of emphysema. Paper presented at: ATS Internatinal Conference; 2013; Philadelphia, PA.
14. Yin Y, Newell J, Raffy P. Automatic quantification of lung fissure integrity in subjects with severe emphysema. Paper presented at: ATS International Conference; 2013; Philadelphia, PA.
15. Boyum A. Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g. Scand J Clin Lab Invest Suppl 1968;97:77–89.
16. Barbano DBA., Resolução RDC n0 9, 14 de março de 2011. Agência Nacional de Vigilância Sanitaria (ANVISA); Diario Oficial da União no 187, Brasilia-DF, Brazil. 2011.
17. Rebelatto CK, Aguiar AM, Moretao MP et al. Dissimilar differentiation of mesenchymal stem cells from bone marrow, umbilical cord blood, and adipose tissue. Exp Biol Med (Maywood) 2008;233:901–913.
18. Borgonovo T, Vaz IM, Senegaglia AC et al. Genetic evaluation of mesenchymal stem cells by G-banded karyotyping in a Cell Technology Center. Rev Bras Hematol Hemoter 2014;36:202–207.
19. Herth FJ, Eberhardt R, Gompelmann D et al. Radiological and clinical outcomes of using Chartis to plan endobronchial valve treatment. Eur Respir J 2013;41:302–308.
20. Oliveira HG, Macedo-Neto AV, Valle E. Using Virtual Bronchoscopy for Emphysema Evaluation and Treatment Planning. 17th World Congress for Bronchology and Interventional Pulmonology, World Association for Bronchology and Interventional Pulmonology. Cleveland, OH, USA; 2012.
21. Celli BR, Locantore N, Yates J et al. Inflammatory biomarkers improve clinical prediction of mortality in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2012;185:1065–1072.
22. Rabe KF, Hurd S, Anzueto A et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007;176: 532–555.
23. Celli BR, Cote CG, Marin JM et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 2004;350:1005–1012.
24. Jones PW, Quirk FH, Baveystock CM et al. A self-complete measure of health status for chronic airflow limitation. The St. George’s Respiratory Questionnaire. Am Rev Respir Dis 1992;145:1321–1327.
25. Zar JH. Biostatistical Analysis. Upper Saddle River, NJ: Prentice-Hall, Inc., 1974.
26. Dahl M, Vestbo J, Lange P et al. C-reactive protein as a predictor of prognosis in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2007;175:250–255.
27. Weiss DJ. Concise review: Current status of stem cells and regenerative medicine in lung biology and diseases. STEM CELLS 2014;32:16–25.
28. McIntyre LA, Moher D, Fergusson DA et al. Efficacy of mesenchymal stromal cell therapy for acute lung injury in preclinical animal models: A systematic review. PLoS One 2016;11:e0147170.
29. Wilson JG, Liu KD, Zhuo H et al. Mesenchymal stem (stromal) cells for treatment of ARDS: A phase 1 clinical trial. Lancet Respir Med 2015;3:24–32.
30. Stolk J, Broekman W, Mauad T et al. A phase I study for intravenous autologous mesenchymal stromal cell administration to patients with severe emphysema. QJM 2016; 109:331–336.